Abstract

Arctium lappa is known to have antioxidant and antidiabetic effects in traditional medicine. Objectives: The aim of this paper was to study the effects of A. lappa root extract (AE) on lipid profile and hepatic enzyme levels in sucrose-induced metabolic syndrome (MS) in female rats. The study used 40 adult female Wistar rats weighing 150 g-250 g randomly divided into five groups: control, metabolic syndrome (MS), metabolic syndrome+AE at 50,100, 200 mg/kg. MS was induced by administering 50% sucrose in drinking water for 6 weeks. AE was intra-peritoneally administered daily at doses of 50,100, and 200 mg/kg for two sequential weeks at the end of the fourth week in metabolic syndrome rats. Twenty-four hours after the last administration of AE, blood was collected and centrifuged, and then the serum was used for the measurement of lipid profile and hepatic enzyme. Serum glucose, insulin, fasting insulin resistance index, body weight, water intake, lipid profile, and hepatic enzymes were significantly increased although food intake was decreased in MS rats compared to the control rats. The lipids and liver enzymes were reduced by AE extracts in the MS group. This study showed that the A. lappa root aqueous extract exhibits a hypolipidemic activity of hyperlipidemic rats. This activity is practically that of a triple-impact antioxidant, hypolipidemic, and hepatoprotective.

Highlights

  • Insulin resistance is the main characteristic of the metabolic syndrome (MS), a complex metabolic disorder described by hypertension, obesity, dyslipidemia, hyperinsulinemia, and type 2diabetes (T2DM)

  • An experimental model that resembles MS can be induced in rats by administering high-fructose or highsucrose (HS) diets

  • Insulin, fasting insulin resistance index, body weight, food intake, water intake, lipid profile, and hepatic enzymes were analyzed by the MS model

Read more

Summary

Introduction

Insulin resistance is the main characteristic of the metabolic syndrome (MS), a complex metabolic disorder described by hypertension, obesity, dyslipidemia, hyperinsulinemia, and type 2diabetes (T2DM). MS is a group of risk factors connected to cardiovascular and chronic liver disorders (Poruba et al, 2015; Flores et al, 2016). This syndrome has a high prevalence all over the world. The recent increase in T2DM and MS is believed to be a consequence of a rise in inactive lifestyles combined with access to energy-rich food (Aguilera et al, 2004; Vinagre et al, 2010).

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call